https://www.biotechblueprint.com/p/revolution-medicines-daraxonrasibBiotech Blueprinten2026-04-17T11:31:21+00:00Revolution Medicines' Daraxonrasib Cuts Pancreatic Cancer Death Risk by 60% – This Week in Biotech #96